Samalin Investment Counsel LLC Raises Stock Holdings in agilon health, inc. (NYSE:AGL)

Samalin Investment Counsel LLC boosted its stake in shares of agilon health, inc. (NYSE:AGL) by 378.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 60,545 shares of the company’s stock after acquiring an additional 47,885 shares during the quarter. Samalin Investment Counsel LLC’s holdings in agilon health were worth $115,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the stock. Oak Thistle LLC purchased a new stake in agilon health during the fourth quarter worth about $25,000. Ieq Capital LLC acquired a new stake in shares of agilon health in the fourth quarter valued at $26,000. Signaturefd LLC raised its stake in shares of agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after acquiring an additional 8,467 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health during the 3rd quarter worth $28,000. Finally, Raymond James Financial Inc. purchased a new position in shares of agilon health in the 4th quarter valued at about $33,000.

agilon health Stock Up 10.1 %

AGL opened at $4.51 on Monday. The business has a 50 day simple moving average of $3.51 and a 200-day simple moving average of $2.94. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The stock has a market capitalization of $1.86 billion, a P/E ratio of -4.80 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Friday. Macquarie began coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective for the company. Sanford C. Bernstein boosted their target price on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. Finally, Stifel Nicolaus increased their price target on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, agilon health has an average rating of “Hold” and a consensus target price of $3.95.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.